Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC) is a potent 12/15-Lipoxygenases (LO) inhibitor. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate has the potential for the research of type 1 diabetes mellitus[1].
Molecular Weight:
321.33
Purity:
99.41
CAS Number:
[132465-11-3]
Formula:
C19H15NO4
Target:
Lipoxygenase
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted